ArticleClinicoEconomics and outcomes research : CEOR2016

UK-specific cost-effectiveness of tiotropium + olodaterol fixed-dose combination versus other LAMA + LABA combinations in patients with COPD.

Abigail Tebboth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.